中国抗体-B(03681)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03681 中国抗体-B

已收盘 12-19 16:08:47

1.030

-0.020

-1.90%

最高1.050	最低1.020	成交量900.00
今开1.050	昨收1.050	日振幅2.86%
总市值11.25亿	流通市值11.25亿	总股本10.92亿
成交额930.00	换手率0.00%	流通股本10.92亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03681","market":"HK","secType":"STK","nameCN":"中国抗体-B","latestPrice":1.03,"timestamp":1734595727016,"preClose":1.05,"halted":0,"volume":900,"delay":0,"floatShares":1091755119,"shares":1091755119,"eps":-0.25614956,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.02,"latestTime":"12-19 16:08:47","open":1.05,"high":1.05,"low":1.02,"amount":930,"amplitude":0.028571,"askPrice":1.08,"askSize":6000,"bidPrice":1.03,"bidSize":33000,"shortable":0,"etf":0,"ttmEps":-0.20495719430490972,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1573488000000,"adjPreClose":1.05,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.007022,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03681","defaultTab":"news","newsList":[{"id":"2492147832","title":"中国抗体-B(03681)：王小素已获委任为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2492147832","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492147832?lang=zh_cn&edition=full","pubTime":"2024-12-19 18:10","pubTimestamp":1734603000,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国抗体-B(03681)发布公告，自2024年12月19日起：(1)石磊因其个人业务安排已辞任非执行董事;及(2)王小素已获委任为非执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","03681","BK1161"],"gpt_icon":0},{"id":"2491656656","title":"中国抗体-B盘中异动 临近收盘股价大跌5.41%报1.050港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491656656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491656656?lang=zh_cn&edition=full","pubTime":"2024-12-16 15:43","pubTimestamp":1734335021,"startTime":"0","endTime":"0","summary":"2024年12月16日临近收盘15时43分，中国抗体-B股票出现异动，股价快速下跌5.41%。截至发稿，该股报1.050港元/股，成交量37.77万股，换手率0.03%，振幅0.90%。资金方面，该股资金流入0港元，流出39.8184万港元。中国抗体-B股票所在的生物技术行业中，整体跌幅为1.44%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216154341a1f265f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216154341a1f265f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","03681"],"gpt_icon":0},{"id":"2490596875","title":"中国抗体-B盘中异动 临近收盘股价大涨5.71%报1.110港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490596875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490596875?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:35","pubTimestamp":1733988910,"startTime":"0","endTime":"0","summary":"2024年12月12日临近收盘15时35分，中国抗体-B股票出现波动，股价快速拉升5.71%。截至发稿，该股报1.110港元/股，成交量24.87万股，换手率0.02%，振幅5.71%。资金方面，该股资金流入1.9734万港元，流出24.621万港元。中国抗体-B股票所在的生物技术行业中，整体跌幅为0.03%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121215351095e92521&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121215351095e92521&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","03681"],"gpt_icon":0},{"id":"2490751788","title":"中国抗体－Ｂ(03681)股价上升5.714%，现价港币$1.11","url":"https://stock-news.laohu8.com/highlight/detail?id=2490751788","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490751788?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:34","pubTimestamp":1733988840,"startTime":"0","endTime":"0","summary":"[上升股]中国抗体－Ｂ(03681) 股价在下午03:34比前收市价上升5.714%，现股价为港币$1.11。至目前为止，今日最高价为$1.11，而最低价为$1.05。总成交量为24.87万股，总成交金额为港币$27.122万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2412123277/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","03681","BK1574"],"gpt_icon":0},{"id":"2490531880","title":"中国抗体-B盘中异动 早盘股价大跌7.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490531880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490531880?lang=zh_cn&edition=full","pubTime":"2024-12-10 11:08","pubTimestamp":1733800130,"startTime":"0","endTime":"0","summary":"2024年12月10日早盘11时08分，中国抗体-B股票出现异动，股价快速下跌7.96%。截至发稿，该股报1.040港元/股，成交量10.83万股，换手率0.01%，振幅7.96%。中国抗体-B股票所在的生物技术行业中，整体跌幅为0.83%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210110850a1e2300a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210110850a1e2300a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","03681"],"gpt_icon":0},{"id":"2490497527","title":"中国抗体(03681.HK)SM17中国1b期临床试验完成全部患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2490497527","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490497527?lang=zh_cn&edition=full","pubTime":"2024-12-09 17:31","pubTimestamp":1733736660,"startTime":"0","endTime":"0","summary":"中国抗体(03681.HK) 公布，于12月4日，SM17(注射用人源化抗IL-25受体单克隆抗体)治疗中重度特应性皮炎的1b期临床试验已在中国完成全部32名患者入组。本项1b期临床试验于6月11日完成首例患者给药，而最后一例受试者最后一次访视(LSLV)预计于明年3月底完成。集团预计明年第一季度能获得顶线数据。此前，公司已分别在美国和中国完成了SM17的I期临床试验。(sl/k)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20201124105434219_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20201124105434219_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1402770/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","03347","BK1161","03681","BK1141","BK1583","BK1576"],"gpt_icon":0},{"id":"2490711970","title":"中国抗体-B盘中异动 下午盘股价大涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490711970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490711970?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:16","pubTimestamp":1733728605,"startTime":"0","endTime":"0","summary":"2024年12月09日下午盘15时16分，中国抗体-B股票出现波动，股价大幅拉升5.61%。中国抗体-B股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，永泰生物-B、嘉和生物-B、云康集团涨幅较大，振幅较大的相关个股有晶泰科技、华康生物医学、永泰生物-B，振幅分别为25.30%、19.26%、18.33%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209151645971cb832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209151645971cb832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","03681"],"gpt_icon":0},{"id":"2488115595","title":"中国抗体-B(03681)与云顶新耀-B(01952)授权合作获进展，新型BTK抑制剂SN1011在1b/2a期临床试验阶段性数据中取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2488115595","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488115595?lang=zh_cn&edition=full","pubTime":"2024-12-04 16:00","pubTimestamp":1733299253,"startTime":"0","endTime":"0","summary":"2024 年 12 月 4 日，中国抗体制药有限公司合作伙伴Everest Medicines宣布其首个公布的具有全球权益的管线产品——EVER001胶囊在治疗原发性膜性肾病的 1b/2a 期临床试验阶段性数据报告中观察到了积极结果。中国抗体-B及信诺维于2021 年 9 月与云顶新耀-B签订独家许可协议, 向云顶新耀授出SN1011在全球范围内用于治疗肾脏疾病的开发、生产和商业化的权利。该研究结果支持SN1011进一步临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1220202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1576","03347","BK1141","BK1574","BK1161","03681","01952"],"gpt_icon":0},{"id":"2488139142","title":"中国抗体-B盘中异动 下午盘股价大跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488139142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488139142?lang=zh_cn&edition=full","pubTime":"2024-12-04 13:57","pubTimestamp":1733291858,"startTime":"0","endTime":"0","summary":"2024年12月04日下午盘13时57分，中国抗体-B股票出现波动，股价急速下跌5.61%。截至发稿，该股报1.010港元/股，成交量1500股，换手率0.00%，振幅0.93%。中国抗体-B股票所在的生物技术行业中，整体跌幅为0.61%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。该公司研发药物用于治疗类风湿关节炎、系统性红斑狼疮、哮喘、天疱疮、干燥综合症及其他免疫性疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204135738971b87d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204135738971b87d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","03681","BK1574"],"gpt_icon":0},{"id":"2486052366","title":"中国抗体-B盘中异动 快速跳水6.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486052366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486052366?lang=zh_cn&edition=full","pubTime":"2024-11-28 15:28","pubTimestamp":1732778914,"startTime":"0","endTime":"0","summary":"2024年11月28日下午盘15时28分，中国抗体-B股票出现波动，股价快速下挫6.48%。截至发稿，该股报1.010港元/股，成交量6.33万股，换手率0.01%，振幅6.48%。中国抗体-B股票所在的生物技术行业中，整体跌幅为1.33%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。该公司研发药物用于治疗类风湿关节炎、系统性红斑狼疮、哮喘、天疱疮、干燥综合症及其他免疫性疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112815283498e45175&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112815283498e45175&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","03681"],"gpt_icon":0},{"id":"2486369878","title":"中国抗体－Ｂ(03681)股价下跌6.481%，现价港币$1.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2486369878","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486369878?lang=zh_cn&edition=full","pubTime":"2024-11-28 15:28","pubTimestamp":1732778880,"startTime":"0","endTime":"0","summary":"[下跌股]中国抗体－Ｂ(03681) 股价在下午03:28比前收市价下跌6.481%，现股价为港币$1.01。至目前为止，今日最高价为$1.08，而最低价为$1.01。总成交量为6.33万股，总成交金额为港币$6.834万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2411281634/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","03681","BK1574"],"gpt_icon":0},{"id":"2486048871","title":"中国抗体-B盘中异动 股价大跌7.41%报1.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486048871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486048871?lang=zh_cn&edition=full","pubTime":"2024-11-26 13:43","pubTimestamp":1732599825,"startTime":"0","endTime":"0","summary":"2024年11月26日下午盘13时43分，中国抗体-B股票出现异动，股价快速下挫7.41%。截至发稿，该股报1.000港元/股，成交量31.35万股，换手率0.03%，振幅9.26%。资金方面，该股资金流入0港元，流出25.6122万港元。中国抗体-B股票所在的生物技术行业中，整体涨幅为0.09%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126134345abdfabbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126134345abdfabbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","03681","BK1161"],"gpt_icon":0},{"id":"2486740252","title":"中国抗体-B盘中异动 早盘股价大跌5.36%报1.060港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486740252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486740252?lang=zh_cn&edition=full","pubTime":"2024-11-25 10:57","pubTimestamp":1732503451,"startTime":"0","endTime":"0","summary":"2024年11月25日早盘10时57分，中国抗体-B股票出现异动，股价急速跳水5.36%。截至发稿，该股报1.060港元/股，成交量1.2万股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出1.272万港元。中国抗体-B股票所在的生物技术行业中，整体涨幅为0.91%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125105732a2533b3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125105732a2533b3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","03681","BK1574"],"gpt_icon":0},{"id":"2485401067","title":"中国抗体-B盘中异动 大幅下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485401067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485401067?lang=zh_cn&edition=full","pubTime":"2024-11-22 11:58","pubTimestamp":1732247897,"startTime":"0","endTime":"0","summary":"2024年11月22日临近午盘11时58分，中国抗体-B股票出现波动，股价快速下跌5.13%。中国抗体-B股票所在的生物技术行业中，整体跌幅为1.08%。其相关个股中，嘉和生物-B、来凯医药-B、宜明昂科-B涨幅较大，振幅较大的相关个股有华领医药-B、来凯医药-B、晶泰科技，振幅分别为16.67%、13.83%、10.40%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112211581898e44134&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112211581898e44134&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03681","BK1161","BK1574"],"gpt_icon":0},{"id":"2485501404","title":"中国抗体－Ｂ(03681)股价下跌5.128%，现价港币$1.11","url":"https://stock-news.laohu8.com/highlight/detail?id=2485501404","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485501404?lang=zh_cn&edition=full","pubTime":"2024-11-22 11:58","pubTimestamp":1732247880,"startTime":"0","endTime":"0","summary":"[下跌股]中国抗体－Ｂ(03681) 股价在上午11:58比前收市价下跌5.128%，现股价为港币$1.11。至目前为止，今日最高价为$1.15，而最低价为$1.11。总成交量为39.9万股，总成交金额为港币$44.289万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2411222444/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","03681","BK1574"],"gpt_icon":0},{"id":"2485884934","title":"中国抗体-B盘中异动 早盘股价大涨7.76%报1.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485884934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485884934?lang=zh_cn&edition=full","pubTime":"2024-11-21 10:12","pubTimestamp":1732155122,"startTime":"0","endTime":"0","summary":"2024年11月21日早盘10时12分，中国抗体-B股票出现波动，股价大幅上涨7.76%。截至发稿，该股报1.250港元/股，成交量9600股，换手率0.00%，振幅0.00%。资金方面，该股资金流入1.2万港元，流出0港元。中国抗体-B股票所在的生物技术行业中，整体跌幅为0.25%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121101202971a7caf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121101202971a7caf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03681","BK1574","BK1161"],"gpt_icon":0},{"id":"2484403660","title":"中国抗体-B盘中异动 早盘急速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484403660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484403660?lang=zh_cn&edition=full","pubTime":"2024-11-18 10:41","pubTimestamp":1731897714,"startTime":"0","endTime":"0","summary":"2024年11月18日早盘10时41分，中国抗体-B股票出现波动，股价大幅拉升5.17%。中国抗体-B股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，中国抗体-B、贝康医疗-B、科济药业-B涨幅较大，振幅较大的相关个股有正大企业国际、百奥赛图-B、荃信生物-B，振幅分别为15.43%、14.59%、13.77%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118104154971a709c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118104154971a709c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03681","BK1161","BK1574"],"gpt_icon":0},{"id":"2483367183","title":"中国抗体－Ｂ(03681)股价上升6.195%，现价港币$1.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2483367183","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483367183?lang=zh_cn&edition=full","pubTime":"2024-11-15 10:00","pubTimestamp":1731636000,"startTime":"0","endTime":"0","summary":"[上升股]中国抗体－Ｂ(03681) 股价在上午10:00比前收市价上升6.195%，现股价为港币$1.2。至目前为止，今日最高价为$1.2，而最低价为$1.05。总成交量为600股，总成交金额为港币$675。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241115575/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03681","BK1574","BK1161"],"gpt_icon":0},{"id":"2483646113","title":"中国抗体-B盘中异动 大幅跳水7.08%报1.050港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483646113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483646113?lang=zh_cn&edition=full","pubTime":"2024-11-15 09:39","pubTimestamp":1731634762,"startTime":"0","endTime":"0","summary":"2024年11月15日早盘09时39分，中国抗体-B股票出现异动，股价快速下跌7.08%。截至发稿，该股报1.050港元/股，成交量300股，换手率0.00%，振幅0.00%。资金方面，该股资金流入315港元，流出0港元。中国抗体-B股票所在的生物技术行业中，整体涨幅为0.09%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115093922a23925c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115093922a23925c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","03681","BK1574"],"gpt_icon":0},{"id":"2483893417","title":"中国抗体-B股价上涨10.28% 市值涨1.32亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483893417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483893417?lang=zh_cn&edition=full","pubTime":"2024-11-14 10:16","pubTimestamp":1731550578,"startTime":"0","endTime":"0","summary":"2024年11月14日早盘10时16分，中国抗体-B股票出现波动，股价大幅上涨10.28%。截至发稿，该股报1.180港元/股，成交量30.12万股，换手率0.03%，振幅11.21%。资金方面，该股资金流入32.8548万港元，流出2.5842万港元。中国抗体-B股票所在的生物技术行业中，整体跌幅为0.65%。其相关个股中，晶泰科技、中国抗体-B、康宁杰瑞制药-B涨幅较大，振幅较大的相关个股有晶泰科技、圣诺医药-B、康宁杰瑞制药-B，振幅分别为32.92%、11.62%、9.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114101618a235adce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114101618a235adce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03681","BK1574","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinomab.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1026},{"period":"3month","weight":-0.1393},{"period":"6month","weight":-0.3675},{"period":"1year","weight":-0.3438},{"period":"ytd","weight":-0.375}],"compareEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.1018},{"period":"1year","weight":0.2035},{"period":"ytd","weight":0.1653}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的香港生物制药公司。该公司主要研制以单克隆抗体为基础的生物制剂和和新化学实体。该公司主要产品SM03是治疗类风湿关节炎的潜在单抗药物。该公司研发药物用于治疗类风湿关节炎、系统性红斑狼疮、哮喘、天疱疮、干燥综合症及其他免疫性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.013788},{"month":2,"riseRate":0.2,"avgChangeRate":-0.060562},{"month":3,"riseRate":0.2,"avgChangeRate":-0.049178},{"month":4,"riseRate":0.8,"avgChangeRate":0.04218},{"month":5,"riseRate":0.2,"avgChangeRate":0.013437},{"month":6,"riseRate":0.2,"avgChangeRate":-0.022623},{"month":7,"riseRate":0.2,"avgChangeRate":-0.070691},{"month":8,"riseRate":0.2,"avgChangeRate":-0.116108},{"month":9,"riseRate":0.4,"avgChangeRate":-0.010658},{"month":10,"riseRate":0,"avgChangeRate":-0.065544},{"month":11,"riseRate":0.8,"avgChangeRate":0.007767},{"month":12,"riseRate":0.333333,"avgChangeRate":0.11005}],"exchange":"SEHK","name":"中国抗体-B","nameEN":"SINOMAB BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国抗体-B(03681)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国抗体-B(03681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国抗体-B,03681,中国抗体-B股票,中国抗体-B股票老虎,中国抗体-B股票老虎国际,中国抗体-B行情,中国抗体-B股票行情,中国抗体-B股价,中国抗体-B股市,中国抗体-B股票价格,中国抗体-B股票交易,中国抗体-B股票购买,中国抗体-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国抗体-B(03681)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国抗体-B(03681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}